πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 369 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7521418

Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacteri

Theravance, Inc. Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521561

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521041

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521558

Crystalline form of a biphenyl compound

Theravance, Inc. Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514425

Short-acting sedative hypnotic agents for anesthesia and sedation

Theravance, Inc. Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514558

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507751

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501442

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498442

Quinolinone-carboxamide compounds

Theravance, Inc. Β· Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491736

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479562

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468420

Process for purifying glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7456199

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7456203

Muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452995

Aryl aniline Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452861

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial a

Theravance, Inc. Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7446114

Quinolinone compounds as 5-HT4 receptor agonists

Theravance, Inc. Β· Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427639

Ξ²2-adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7419989

Indazole-carboxamide compounds

Theravance, Inc. Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405199

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7402673

Diamine Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7399862

5-HT4 receptor agonist compounds

Theravance, Inc. Β· Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7399863

Amino-substituted ethylamino Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396933

Quinolinone-carboxamide compounds

Theravance, Inc. Β· Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted